WCLC 2025 - Posters & ePosters-P3.12.39 Long-Term Overall Survival in Advanced EGFRm NSCLC Treated With 1L Osimertinib: Results From the US, Japan, Germany and China

P3.12.39 Long-Term Overall Survival in Advanced EGFRm NSCLC Treated With 1L Osimertinib: Results From the US, Japan, Germany and China

Asset Subtitle

Jorge Nieva

Meta Tag

Speaker Jorge Nieva

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy